Elevations in glucocorticoid levels (GCs) in breeding females may induce adaptive shifts in 26 offspring life histories. Offspring produced by mothers with elevated GCs may be better 27 prepared to face harsh environments where a faster pace of life is beneficial. We examined how 28 experimentally elevated GCs in pregnant or lactating North American red squirrels 29 (Tamiasciurus hudsonicus) affected offspring postnatal growth, structural size, oxidative stress 30 levels (two antioxidants and oxidative protein damage) in three different tissues (blood, heart, 31 liver), and liver telomere lengths. We predicted that offspring from mothers treated with GCs 32 would grow faster but would also have higher levels of oxidative stress and shorter telomeres, 33 which may predict reduced longevity. Offspring from mothers treated with GCs during 34 pregnancy were 8.3% lighter around birth but grew (in body mass) 17.0% faster than those from 35 controls, whereas offspring from mothers treated with GCs during lactation grew 34.8% slower 36 than those from controls and did not differ in body mass around birth. Treating mothers with 37
Introduction 56
Parents can have long-lasting impacts on their offspring across a diversity of taxa. These 57 parental effects have drawn substantial interest because they suggest that parental characteristics 58 or the parental environment itself could induce adaptive shifts in offspring traits that prepare 59 them for specific environments (i.e., adaptive transgenerational phenotypic plasticity: Mousseau 60 and Fox, 1998; Agrawal et al., 1999; Galloway and Etterson, 2007; Dantzer et al., 2013) . Maternal GCs could also act as an internal cue for offspring to modify their own development 73 (Nettle et al., 2013) . Regardless of the pathway, there is much evidence that changes in maternal 74
GCs mediate parental effects whose influence may even persist across generations via epigenetic 75 mechanisms (Weaver et al., 2004) . 76 Some of these changes in offspring characteristics that are caused by elevations in 77 maternal GCs are suspected to reflect adaptive plasticity in offspring life history traits, such as 78 modifying the trade-off between early life growth and lifespan (Monaghan and Haussmann, 79 2015; Berghänel et al., 2017) . Elevated maternal GCs may induce a "faster" life history strategy 80 whereby offspring produced by mothers with elevated GCs grow or develop faster (Dantzer et 81 al., 2013; Berghänel et al., 2016) . Such adjustments in the "pace of life" may be adaptive, as fast 82 postnatal growth or a quicker developmental time may be beneficial when the risk of extrinsic 83 mortality is heightened (Reznick et al., 1990; Stearns et al., 2000) , which may coincide with 84 elevated maternal GCs. However, this increased investment in postnatal growth is expected to 85 carry costs for offspring longevity whereby fast-growing individuals exhibit a shortened lifespan 86 history traits. Furthermore, avian or mammalian species with longer lifespans have been shown 118 to exhibit slower age-specific rates of telomere loss (Haussmann et al., 2003; Dantzer and 119 Fletcher, 2015; Sudyka et al., 2016; Tricola et al., 2018) . 120
Elevated exposure to maternal GCs may, therefore, induce a life history trade-off 121 between offspring growth and longevity, because offspring may experience elevated oxidative 122 damage, decreased antioxidant levels, and/or shortened telomeres, either due to oxidative stress 123 or increased cell division associated with elevated growth (Shalev, 2012; Haussmann and 124 Heidinger, 2015; Monaghan and Haussmann, 2015 ; Shalev and Belsky, 2016; Monaghan and 125 Haussmann, 2018) . Previous studies across taxa show that elevated exposure to maternal GCs 126 can shorten telomere lengths in offspring (Entringer et al., 2011; Haussmann et al., 2012; 127 Herborn et al., 2014; Marchetto et al., 2016) or increase their rate of attrition as they age 128 (Haussmann and Heidinger, 2015) , which could cause or be associated with a shortened lifespan. 129
For example, experimental studies in captive and wild birds show that offspring that had 130
exogenous GCs added to their eggs or were administered GCs during chick growth had a 131 heightened physiological stress response, higher levels of oxidative stress, and shorter telomeres 132 early in life (Haussmann et al., 2012; Herborn et al., 2014) . Despite much interest in this topic, 133 few studies in wild animals have examined if experimental elevations in the GCs of breeding 134 females impact the oxidative state of offspring or explicitly tested the prediction that elevations 135 in the GCs of breeding females increase early life growth. Additionally, few studies have tested 136 whether elevated GCs in breeding females or fast early life growth comes at some cost by 137 promoting oxidative stress and shortening telomeres in offspring. 138
We tested the hypothesis that elevations in maternal GCs would promote a faster life 139 history strategy in offspring of wild North American red squirrels (Tamiasciurus hudsonicus). 140
We treated females with GCs using a protocol that allowed us to increase circulating GCs within 141 a physiologically-relevant range (van Kesteren et al., 2019). We treated females with GCs either 142 during pregnancy or lactation to assess if the timing of exposure to maternal GCs influenced 143 their effects on offspring. Other than for offspring growth in body mass, we did not have strong a 144 priori expectations of how the timing of elevated maternal GCs would differentially impact 145 offspring because elevated maternal GCs during pregnancy or lactation can impact offspring 146 through the same pathways: direct transfer of maternal GCs to offspring across the placenta or 147 through milk ("programming"), altering maternal behaviour, or affecting offspring behaviour 148 (see references above). However, based upon our previous study (Dantzer et al., 2013) , we 149 predicted that offspring produced by mothers treated with GCs during pregnancy would grow 150 faster in body mass. We did not have an a priori expectation for how treating mothers with GCs 151 during lactation would impact offspring growth in body mass, though results from a previous 152 study suggested that it should reduce growth (Nephew and Bridges, 2011) . 153
We measured offspring postnatal growth in body mass prior to weaning (~1 to 25 d of 154 age) and subsequently obtained measures of oxidative stress when pups were weaned (~70 d of 155 age). In three tissues (liver, heart muscle, and blood) collected from weaned offspring, we 156 measured one enzymatic antioxidant (superoxide dismutase), one type of non-enzymatic 157 antioxidant (total antioxidant capacity), and one type of oxidative damage (protein damage 158 measured via protein carbonyls). We used multiple tissues because other studies have 159 highlighted how experimental manipulations can have tissue-specific effects (Garratt et al., 160 2012) . To assess the cumulative impact of elevated maternal GCs on the oxidative state of 161 offspring and how offspring growth impacted telomere lengths, we also measured telomere 162 lengths in DNA from the liver. We focused on liver telomere lengths because the liver is a 163 mitotically active tissue, produces growth hormones, and previous studies have documented a 164 reduction in telomere length with faster growth (Monaghan and Ozanne, 2018), suggesting that 165 the liver would be a good tissue to investigate any oxidative costs of growth. Although we only 166 measured telomere lengths in one tissue, previous studies indicate that telomere lengths 167 measured in one somatic tissue are strongly correlated with those in others (Friedrich et al., 168 2000) . Because our estimate of offspring growth from ~1 to 25 d of age was temporally 169 separated from when we obtained our measures of oxidative stress and telomere lengths (when 170 offspring were weaned [~70 d]), we were able to assess whether there were persistent or 171 cumulative oxidative costs to fast growth. 172
We predicted that offspring from mothers treated with GCs during pregnancy would 173 grow quicker in body mass after birth, but would experience more oxidative stress (manifested as 174 a reduction in antioxidants and an increase in oxidative damage) and decreased telomere length, 175 which would be a result of increased oxidative stress or increased cell division associated with 176 faster growth. Because we have previously found that female red squirrels can ameliorate the 177 trade-off between offspring number and growth (Dantzer et al., 2013; Westrick et al., 2019 178 preprint), we examined if elevated maternal GCs altered the trade-off between litter size and 179 offspring growth or structural (skeletal) size. Previous studies highlight that elevated maternal 180
GCs can impact offspring birth weight (Berghänel et al., 2017) so we also examined the 181 treatment effects on the first measure of body mass. Because early life exposure to GCs may 182 modify the direction and strength of the association between two variables (Careau et al., 2014; 183 Merill and Grindstaff, 2018), we also examined if increases in maternal GCs affected the 184 expected negative relationship between offspring growth and oxidative stress state (Smith et al., 185 2016) by assessing the statistical interaction between offspring growth and maternal treatment. 186 187
Materials and Methods 188

Study area & measuring offspring growth 189
We conducted this study as a part of a long-term study of red squirrels in the Yukon, 190 Canada that takes place on the traditional territory of the Champagne and Aishihik First Nations. 191
Squirrels in our study population were all marked individually with unique ear tags and 192 combinations of coloured wire threaded through the ear tags (McAdam et al., 2007) . Females in 193 our study population usually produce one litter in the spring, and rarely produce more than one 194 litter of offspring to weaning per year (Boutin et al., 2006) . Adult females were captured and 195 handled every ~3 to 21 d to assess reproductive status through abdominal palpation and nipple 196 condition. Pups were retrieved from the nest two times. The first nest entry occurred immediately 197 after parturition and the second nest entry occurred when pups were approximately 25 d of age. 198
At both nest entries, pups were briefly removed from their nest, sexed, and weighed to the 199 nearest 0.01 g using a portable balance. At the first nest entry, we marked them uniquely by 200 obtaining a small ear biopsy (for later paternity analyses) and then we permanently marked pups 201 at the second nest entry with unique metal ear tags. Because offspring growth in body mass 202 during this period of time is approximately linear (McAdam et al., 2002) , we estimated offspring 203 growth as the change in body mass from the first to second nest entry divided by the total 204 number of days elapsed between the two measures of body mass. Red squirrels usually first 205 emerge from their nest around 30-35 d old and are usually weaned around 70 d old, such that this 206 period of growth from ~1-25 d of age represents a period in which offspring are only consuming 207 milk from their mother. At the second nest entry, we measured zygomatic arch width and right 208 hind foot length to the nearest 1 mm using digital callipers or a ruler, respectively. Because we 209 only obtained these morphological measures at the second nest entry (when pups were ~25 d 210 old), we were not able to measure the change in offspring structural size as we did for growth. 211
All of our procedures were approved by the Animal Care and Use Committee at the University 212 of Michigan (PRO00007805). 213
Maternal treatments 214
We used four separate treatment groups to assess the effects of elevated maternal GCs on 215 offspring over four different years (2012, (2015) (2016) (2017) , although in 2012 we only collected 216 growth in body mass data. Individual adult females were treated with GCs either during 217 pregnancy or lactation ("Pregnancy GCs" and "Lactation GCs"), whereas other females were 218 treated as controls during pregnancy or lactation ("Pregnancy Controls" or "Lactation Controls"). 219
We increased maternal GCs either during pregnancy or lactation using an established 220 experimental protocol (Dantzer et al., 2013; van Kesteren et al., 2019) . Briefly, we treated 221 females in the Pregnancy GCs (n = 44 total litters from 43 unique females) and Lactation GCs (n 222 = 18 litters from 17 unique females) treatment groups with exogenous cortisol (hydrocortisone, 223
Sigma H4001) dissolved in peanut butter and wheat germ mixture (8 g of peanut butter, 2 g of 224 wheat germ). Females in the Pregnancy Control (n = 31 total litters from 32 unique females) or 225
Lactation Control (n = 17 litters from 16 unique females) treatment groups were fed the same 226 amount of peanut butter and wheat germ mixture but lacking the hydrocortisone. GC treatments 227
were prepared by dissolving hydrocortisone in 1 mL of 100% ethanol and then 5 mL of 100% 228 peanut oil before allowing the emulsion to sit overnight so that the ethanol could evaporate. The 229 following morning, the hydrocortisone emulsion was thoroughly mixed with the appropriate 230 amount of peanut butter and wheat germ, weighed out into individual dosages (~10 g each), 231 placed into an individual container, and then frozen at -20 °C until provisioning to the treated 232
squirrels. 233
Each day during the treatment period, we placed individual dosages into a bucket that 234 was hung ~7-10 m off the ground on the centre of the squirrel's territory. Squirrels defend these 235 buckets from all other conspecifics and heterospecifics (van Kesteren et al., 2019), so we can, 236 therefore, be confident that the squirrels that were given these treatments were consuming them. 237
The dosage of hydrocortisone varied among some of the treatment groups but we have 238 previously shown that either 3, 6, 8, or 12 mg of hydrocortisone per day significantly elevates 239 baseline plasma cortisol and faecal glucocorticoid metabolite levels but within a physiologically-240 relevant range (Dantzer et al., 2013; van Kesteren et al., 2019) . Females in the Pregnancy GCs 241 treatment group were provisioned either with 3 mg (n = 4 litters), 6 mg (n = 6 litters), 8 mg (n = 242 26 litters), or 12 mg (9 litters) of hydrocortisone whereas females in the Lactation GCs treatment 243 groups were provisioned either with 8 mg per day (n = 10 litters) or 12 mg per day (n = 8 litters). 244
Although the dosage administered to females treated during pregnancy or lactation varied, we 245 grouped those administered GCs in the same treatment group regardless of dosage (i.e., 246
Pregnancy GCs contained females administered 3-12 mg of hydrocortisone per day, Lactation 247
GCs contained females administered 8 or 12 mg of hydrocortisone per day). We did this for three 248 reasons. First, we have previously shown that females provisioned with 6, 8, or 12 mg of 249 hydrocortisone per day did not differ in their faecal glucocorticoid metabolite levels (FGM), 250 although there were non-significant trends where squirrels fed higher dosages of hydrocortisone 251 had higher FGM (van Kesteren et al., 2019). Second, in preliminary analyses of the data 252 presented here and in a previous study (Dantzer et al., 2013) , we found that the effects of 253 different GC dosages (3, 6, 8, and 12 mg per day) that were provided to pregnant females on 254 offspring growth were in the same direction (increased postnatal growth: Table S1 ). For females 255 treated with Lactation GCs (8 or 12 mg per day), we also found that the effects on offspring 256 growth were in the same direction (decreased postnatal growth: Table S1 ). Finally, our sample 257 sizes in some of the treatment groups (3 and 6 mg per day in the Pregnancy GCs treatment 258 group) were too small to assess whether there were statistical differences among the different 259 dosage groups. 260
We aimed to treat females in the pregnancy treatments from approximately 20 d after 261 conception until 5 d after birth (or 20-40 d post-conception as red squirrels on average have a 262 ~35 d gestation period), whereas we actually treated females in the pregnancy GCs treatment 263 group from 24.2 ± 0.9 d (mean ± SE) to 39.0 ± 0.6 d post-conception (mean ± SE treatment 264 duration: 14.9 d ± 0.8 d) and females in the pregnancy control treatment group from 20.4 ± 0.8 d 265 to 38.6 ± 0.5 d (treatment duration: 18.2 ± 0.8 d). We aimed to treat females in the lactation 266 treatments from approximately 5 d after parturition until 15 d post-parturition, whereas we 267 actually treated females in the Lactation GCs treatment group from 5.4 ± 0.5 d (mean ± SE) to 268 14.5 ± 0.6 d post-conception (mean ± SE treatment duration: 9.1 d ± 0.1 d) and females in the 269 Lactation Control treatment group from 4.9 ± 0.4 d to 14.1 ± 0.5 d (treatment duration: 9.2 ± 0.5 270 d). Given a ~35 d gestation period and a ~70 d lactation period in this population, our pregnancy 271 treatments corresponded to treating females during the last trimester of gestation and into the 272 first few days of lactation, whereas our lactation treatments corresponded to early lactation 273 before offspring begin to feed independently (they typically leave the nest on their own for the 274 first time at ~35 d). Note that this means that the lactation treatments occurred during a time 275 when the offspring would not be able to consume any of the treatments themselves so any effects 276 on offspring were likely due to the maternal phenotype. (sample sizes shown in Tables 2-4, S1-S5). Below we show that there was no evidence that the 285 treatments had differential effects on litter survival from the first to second nest entry (see 286
Results). 287
Tissue sample collection 288
Pups are weaned when they are approximately ~70 d of age and generally stay on their 289 natal territory until dispersal soon after (Larsen and Boutin, 1994) . When juvenile squirrels were 290 ~70 d of age, they were euthanized and tissues (liver and cardiac muscle) were immediately 291 removed, rinsed with PBS buffer, snap frozen on dry ice, and then stored in liquid nitrogen or in 292 a -80 °C freezer until analysis. Trunk blood was collected through decapitation and then 293 centrifuged at 10,000 g for 10 min at room temperature to separate plasma and red blood cells. 294
Haematocrit 295
We measured packed red blood cell volume (haematocrit) as a measure of body condition 296 as some (though not all) previous studies have found that higher haematocrit levels correspond to 297 better body condition or improved reproductive performance, at least in some studies of wild 298 birds (Breuner et al., 2013; Minias, 2015; Fronstin et al., 2016) . Before pups were euthanized, we 299 collected a blood sample from the hind nail into a heparinized capillary tube. Haematocrit was 300 quantified using a micro-capillary reader after centrifuging blood samples at 10,000 g for 10 min 301 at room temperature. 302
Protein carbonyls 303
We measured oxidative damage to proteins (Monaghan et al., 2009) using the protein 304 carbonyl colorimetric kit by Cayman Chemical (Ann Arbor, USA). Briefly, ~200 mg of cardiac 305 muscle or liver were homogenized in ~1000 µL of 50mM MES buffer containing 1mM EDTA 306 using a sonicator, and then centrifuged at 10,000 g for 15 min at 4 °C. The protein concentration 307 of tissue homogenate supernatant and plasma samples was measured prior to the assay using a 308
Biotek Take3 protocol (Biotek, Vermont, USA) and samples were diluted in PBS buffer to give a 309 protein range between 1-10 mg/ml, as recommended by the manufacturer. The average intra-310 assay CV for samples for plasma, heart, or liver were 1.2%, 2.8%, and 1.6%, respectively. Inter-311 assay CVs for a red squirrel pooled sample run on repeat assays for plasma (n = 7 assays), heart 312 (n = 6), or liver (n = 7) were 3.5%, 9.0%, and 8.3%, respectively. We also ran a positive control 313 (oxidized bovine serum albumin) in two different assays and the inter-assay CV was 3.1%. 314
Superoxide dismutase 315
We obtained one measure of the levels of enzymatic antioxidants ) 316 by quantifying levels of superoxide dismutase (SOD) using the SOD kit from Cayman Chemical. 317 SOD was expressed as units/mg/ml protein (quantified using a Biotek Take3 protocol). Red 318 blood cells were lysed as per the manufacturer's protocol. The average intra-assay CV for 319 samples for RBCs, heart, or liver were 2.3%, 4.7%, and 3.1%, respectively. Inter-assay CVs for a 320 red squirrel pooled sample run on repeat assays for RBCs (n = 10 assays), heart (n = 2), or liver 321 (n = 4) were 16.9%, 4.6%, and 6.5%, respectively. 322
Total antioxidant capacity 323
We obtained one measure of the levels of non-enzymatic antioxidants (Monaghan et al., 324 2009) by quantifying total antioxidant capacity (TAC) using the TAC kit from Cayman 325
Chemical. Plasma was diluted in assay buffer and assayed according to the manufacturer's 326 protocol. Liver and cardiac muscle (~47 mg) were separately homogenized in 250 µL PBS using 327 a sonicator and the supernatant was diluted in assay buffer and used in the assay. The average 328 intra-assay CVs for samples for plasma, heart, or liver were 4.7%, 3.2%, and 4.7%, respectively. 329
The inter-assay CVs for standards run on all the plates for plasma (n = 5 assays) was 15.8% 330 whereas the inter-assay CV for a red squirrel pooled sample run on repeat for heart (n = 8) or 331 liver (n = 2) were 15.4% and 5.4%, respectively. 332
Telomeres 333
Liver telomere lengths were measured using the telomere restriction fragment (TRF) 334 assay following established methods (Haussmann and Mauck, 2008) . Briefly, 2 to 10 g slices of 335 liver tissue were homogenized in cell lysis solution and proteinase K (Qiagen, Germantown, 336 USA). DNA was extracted from the liver homogenates and resuspended in buffer. The 337 resuspended DNA was restriction digested with 15 U of HinfI, 75U of HaeIII and 40U of RsaI 338 (New England BioLabs, Ipswich, USA) at 37 °C. DNA was then separated using pulsed field 339 electrophoresis at 14˚C for 19 hours followed by in-gel hybridization overnight at 37˚ C with a 340 radioactively labeled telomere-specific oligo (CCCTAA) 4 . Hybridized gels were placed on a 341 phosphorscreen (Amersham Biosciences, Buckinghamshire, UK), which was scanned on a 342
Typhoon Imager (Amersham Biosciences). Densitometry in ImageJ (v. 1.51s) was used to 343 determine the position and the strength of the radioactive signal in each of the lanes compared 344 with the molecular marker (Quick-Load1 kb DNA Extend DNA Ladder; New England BioLabs) 345
to calculate telomere lengths for each sample. Inter-gel variation was accounted for by 346 calculating the mean TRF length of standard samples run on each gel. 347
Statistical analyses 348
We assessed the effects of maternal treatments on litter survival from the first to second 349 nest entry (proportion of pups present at both first and second nest entries) and litter size and and pregnancy treatments were run separately. There was one litter from a Pregnancy Control 355 treatment female where her litter size at the second nest entry was greater than the at the first, 356 likely because we missed a pup in the nest at the first nest entry, and we therefore excluded this 357 litter from our analyses of the effects of the treatments on litter survival, litter size, and litter sex 358 ratio. We confirmed that none of the GLMMs were overdispersed as all dispersion parameters 359 were <1. 360
We assessed the effects of maternal treatments on offspring body mass at the first nest 361 entry soon after parturition (birth mass), growth in postnatal body mass, and a single measure of 362 size using separate LMMs for pregnancy and lactation treatments. Each of the six LMMs (one 363 model for birth mass, one model for growth, and one model for size for pregnancy treatments; 364 one model for birth mass, one model for growth, and one model for size for lactation treatments) 365 included a fixed effect for maternal treatment and covariates (sex, year [categorical variable], 366 birth date, litter size) that could impact offspring birth mass, growth, or size. We included a two-367 way interaction term between treatment and litter size to identify if elevations in maternal GCs 368 altered the trade-off between litter size and offspring birth mass, growth, or size, as shown 369 previously for offspring growth (Dantzer et al., 2013) . We included a two-way interaction 370 between treatment and sex to assess if the treatments had sex-specific effects on birth mass, 371 growth, and size, as documented in other species (Dantzer et al., 2019 ). In our model for the 372 effects of the treatments on offspring birth mass, we included a fixed effect for age of the pups to 373 control for the impact of age on body mass. We used a principal component analysis (PCA) 374 our measures of oxidative damage (Costantini and Verhulst, 2009 ). We used a PCA to create a 384 composite variable that reflected the oxidative state of an offspring. The PCA was composed of 385 the two antioxidants (SOD, TAC) and one measure of oxidative damage (PCC). We conducted a 386 separate PCA (using a correlation matrix) for each tissue type using the package ade4. For some 387 individuals, we were missing measures of TAC (heart: n = 3; plasma: n = 2) or PCC (heart: n = 388 2; plasma: n = 4) so we substituted average values for the PCA. 389
Low scores for Blood PC2, Heart PC2, or Liver PC1 corresponded to squirrels that were 390 exhibiting oxidative stress as they represented lower levels of the two antioxidants (SOD, TAC) 391 for blood and liver tissue or just one antioxidant (SOD) for heart tissue and, for heart tissue, 392 higher levels of protein damage (PCC, for these variables, we did not include an interaction between sex and treatment. In the model to 401 assess treatment effects on telomere lengths, we also included a fixed effect for the oxidative 402 stress levels in the liver (Liver PC1). oxidative stress, or telomere lengths per individual pup, we did not include random intercept 411 terms for individual identity in any of the models described above. Whenever we had repeated 412 observations of the same litter (e.g., multiple estimates of offspring growth from different pups 413 within the same litter), we included a random intercept term for litter identity. However, we did 414 not include a random intercept in some models (shown in electronic supplementary materials) 415 due to model convergence issues that were likely the result of having only a few observations of 416 multiple pups being measured within one litter or for having a relatively small number of litters. 417
As we had few observations of the same females across years for most of our response variables 418 (sample sizes shown above), we did not include a random intercept for maternal identity as this 419 was usually redundant with litter identity. Random effects were not included in our models of the 420 effects of the treatments on litter characteristics (survival, size, sex ratio) as we only had a few 421 females observed across multiple years. We estimated variance inflation factors (VIFs) from our 422 models to assess multicollinearity among the predictor variables (Zuur et al., 2010) and VIFs 423 indicated that multicollinearity was not an issue in these models (all VIF < 3 except if included 424
in an interaction or a multi-level categorical variable). 425
426
Results 427
Effects of treatments on litter survival, litter size, & litter sex ratio 428
There was no evidence that treating mothers with GCs during pregnancy or lactation 429 caused litter failure or altered litter size or litter sex ratio compared to the controls. For those 430 mothers producing offspring until at least the first nest entry (occurring soon after pups were 431 born), the proportion of the litter that survived from the first to the second nest entry did not 432 differ between mothers treated with GCs during pregnancy (n = 42 litters, 53.8 ± 7% of total 433 pups survived from the first to second nest entry) and the pregnancy (time-matched) controls (n 434 = 29 litters, 63 ± 8%, z = -0.66, P = 0.51), nor between mothers treated with GCs during lactation 435 (n = 18 litters, 79.6 ± 8% pups survived) and the lactation (time-matched) controls (n = 17 litters, 436 72.6 ± 9.5% pups survived, z = -0.63, P = 0.53). 437
Litter size did not differ between mothers treated with GCs during pregnancy or the 438 controls at the first nest entry (Pregnancy GCs: n = 42 litters, 3.07 ± 0.14 pups, range = 1-5 pups; 439
Pregnancy Controls: n = 31 litters, 2.9 ± 0.17 pups, range = 1-5 pups, effect of treatment, t52 = -440 0.19, P = 0.85) nor at the second nest entry (Pregnancy GCs: n = 23 litters, 2.75 ± 0.24 pups, 441 range = 1-5 pups; Pregnancy Controls: n = 20 litters, 2.70 ± 0.16 pups, range = 1-4 pups, effect 442 of treatment, t37 = 0.11, P = 0.92). Litter size also did not differ between mothers treated with 443
GCs during lactation or the controls at the first nest entry (Lactation GCs: n = 18 litters, 2.67 ± 444 0.2 pups, range = 1-4 pups; Lactation Controls: n = 17 litters, 2.94 ± 0.13 pups, range = 2-4 pups, 445 effect of treatment, t30 = -1.11, P = 0.27), nor at the second nest entry (Lactation GCs: n = 16 446 litters, 2.25 ± 0.2 pups, range = 1-3 pups; Lactation Controls: n = 14 litters, 2.57 ± 0.2 pups, 447 range = 1-4 pup, effect of treatment, t25 = -1.31, P = 0.20). 448
The litter sex ratio (proportion of males) at the first nest entry did not differ between 449 mothers treated with GCs during pregnancy or the controls (Pregnancy GCs: n = 42 litters, 53 ± 450 4% males; Pregnancy Controls: n = 29 litters, 40.9 ± 5% males, effect of treatment: z = 0.57, P = 451 0.57), nor at the second nest entry (Pregnancy GCs: n = 23 litters, 59.3 ± 7% males; Pregnancy 452
Controls: n = 19 litters, 46.5 ± 7% males, effect of treatment: z = 0.26, P = 0.80). Similarly, the 453 litter sex ratio at the first nest entry did not differ between mothers treated with GCs during 454 lactation or the controls (Lactation GCs: n = 18 litters, 52.8 ± 7.2% males; Lactation Controls: n 455 = 17 litters, 53.4 ± 7.9% males, effect of treatment: z = 0.09, P = 0.92) nor at the second nest 456 entry (Lactation GCs: n = 16 litters, 58.3 ± 8.7% males; Lactation Controls: n = 14 litters, 64.9 ± 457 9.3% males, effect of treatment: z = -0.27, P = 0.79). 458
Effects of treating pregnant females with GCs on offspring growth, oxidative stress, and telomere 459 lengths 460
Offspring from mothers treated with GCs during pregnancy grew 17.0% faster (t41.4 = 461 3.07, P = 0.004, Table 2A , Fig. 1A ) but were not larger in structural size (Table 2B , Fig. 1C) , 462 and did not differ in body condition (as reflected in their haematocrit levels: Table S2A ) than 463 those produced by control mothers. After correcting for the effects of age on the first body mass 464 we recorded when pups were first weighed ("birth mass") as well as other variables (Table 3A) , 465
offspring from mothers treated with GCs during pregnancy were 8.3% smaller than those from 466 control mothers (t59.8 = -2.51, P = 0.015, Table 3A ), suggesting that these pups exhibited catch-467 up growth after being born at a smaller body mass. There was no indication that the treatments 468 had sex-specific effects on offspring growth or size (Table 2 ). There was also no indication of a 469 trade-off between litter size and offspring growth or size during the years that we studied ( Table  470 2) nor was there any evidence that treating mothers with GCs during pregnancy altered the 471 relationship between litter size and growth rate, as indicated by the lack of significant 472 interactions between treatment and litter size for offspring growth and size (Table 2) . Because 473 the treatments had no significant effects on litter size or litter sex ratio (see above), the effects of 474 the treatments on offspring growth were not simply due to a reduction in litter size. 475
Offspring from mothers treated with GCs during pregnancy did not have higher oxidative 476 stress levels in the blood, liver, or heart (Table S3 , Fig. 2 ) and they also did not have shorter 477 telomere lengths (Table S4 , Fig. 3 ). Offspring from mothers treated with GCs during pregnancy 478 or provided with supplemental food during pregnancy (controls) that grew faster did not have 479 higher oxidative stress levels in blood, heart, or liver nor did they have shorter telomere lengths 480 (Tables S3-S4 ). There was no indication that growth or its interaction with maternal treatment 481 impacted oxidative stress levels (Table S3 ) or liver telomere lengths (Table S4 ) in offspring from 482 females treated during pregnancy. 483
Effects of treating lactating females with GCs on offspring growth, oxidative stress, and telomere 484 lengths 485
Offspring from mothers treated with GCs during lactation grew 34.8% slower (t27 = -486 2.08, P = 0.047, Table 4A , Fig. 1B ), but were not significantly smaller in structural size (Table  487 4B, Fig. 1D ), and did not differ in body condition (as reflected in haematocrit levels: Table S2B ) 488 or first body mass (Table 3B ) from those of pups from control mothers. There was no indication 489 that the treatments had sex-specific effects on offspring growth or size, as reflected in the lack of 490 significant sex by treatment interactions (Table S4 ). There was also no indication of a trade-off 491 between litter size and offspring growth or size (Table S4 ) and no evidence that treating females 492 with GCs during lactation altered the relationship between litter size and growth rate, as 493 indicated by the lack of significant interactions between treatment and litter size for offspring 494 growth and size (Table S4 ). Because the treatments had no significant effects on litter size or 495 litter sex ratio (see above), the effects of the treatments on offspring growth were not simply due 496
to an increase in litter size. 497
Offspring from mothers treated with GCs during lactation did not have higher oxidative 498 stress levels than those from control mothers in any of the three tissues (blood, heart, liver: Table  499 S5, Fig. 2B , 2D, 2F) and they also did not have shorter telomere lengths (Table S4 , Fig. 3B ). 500
Offspring from mothers treated with GCs during lactation or provided with supplemental food 501 during lactation (controls) that grew faster did not have higher oxidative stress levels in blood, 502 heart, or liver nor did they have shorter telomere lengths (Table S4 ). There was also no 503 indication that growth or its interaction with maternal treatment impacted oxidative stress levels 504 (Table S5 ) or liver telomere lengths (Table S4) Mothers treated with GCs during pregnancy produced offspring that were lighter around 509 birth but then exhibited significantly faster postnatal growth prior to weaning, whereas mothers 510 treated with GCs during lactation tended to produce slower growing offspring that were of 511 similar mass at birth. There were no treatment effects on offspring structural size, indicating that 512 while offspring from mothers treated with GCs gained mass at a different rate than the controls, 513 the treatments did not influence skeletal size. However, we only obtained one measure of 514 structural size when offspring were ~25 d of age, and therefore did not quantify any treatment 515 effects in the rate of change in structural size as we did for body mass. Our results differ from a 516 recent literature analysis across mammals showing that offspring from mothers experiencing late 517 gestational stress grew more slowly before weaning (Berghänel et al., 2017) . One explanation for 518 the difference between this previous literature analysis and our results is that elevated GCs 519 simply modulated the trade-off between offspring quantity and quality (e.g., producing small 520 litters of fast-growing offspring) or ameliorated the trade-off between offspring quantity and 521 quality (e.g., lessening the effect of increased litter size on the growth rate of each individual 522 offspring: Stearns, 1992 ). However, this is unlikely because we found no treatment effects on 523 litter size nor on the trade-off between litter size and growth rate. Thus, somehow females treated 524 with GCs during pregnancy produced fast growing offspring without merely reducing their litter 525 sizes, though it is notable that in the years in which we conducted this study, we also did not 526 document a trade-off between litter size and offspring growth in any of the GC-treated or control 527 females, as we have found previously (Dantzer et al., 2013) . It is possible that we did not find 528 evidence of a trade-off between litter size and offspring growth in the present study because both 529 the GC-treated and control females were fed supplemental food and a previous study showed that 530 ad libitum food-supplementation ameliorates this trade-off in red squirrels (Dantzer et al., 2013) . 531
GCs are metabolic hormones that have well-known effects on partitioning resources dedicated to 532 survival vs. reproduction within-individuals (Wingfield et al., 1998) . Here, it is possible that GCs 533 also play a role in the partitioning of resources between mothers and offspring where they 534 increase investment in offspring (increasing postnatal growth rates without a reduction in litter 535 size) perhaps at the expense of maternal energy stores. 536
We did not find support for the hypothesis that elevated maternal GCs during pregnancy 537 or lactation or increased offspring growth caused an elevation in oxidative stress levels or 538 shortened telomere lengths in offspring. This differs from previous studies that have found that 539 offspring growth is positively correlated with oxidative stress levels or inversely correlated with 540 offspring telomere lengths (Haussmann and Heidinger, 2015; Monaghan and Hausssmann, 2015; 541 Monaghan and Ozanne, 2018). This is surprising and requires explanation. First, we measured 542 oxidative stress levels in offspring when they were weaned (~70 d of age) whereas we treated 543 their mothers with GCs either during pregnancy or early lactation. Thus, it is possible that the 544 offspring in our study experienced elevated oxidative stress levels but these effects had 545 disappeared by weaning. A second possibility is an artefact associated with selective 546 disappearance of poor-quality individuals from those mothers treated with GCs during 547 pregnancy, such as slow growing individuals with short telomeres dying before we could obtain 548 our measures of oxidative stress and telomere lengths. This is unlikely as we observed no 549 treatment effects on litter size or the reduction in litter size from the first to second nest entry. 550
Finally, the fact that mothers treated with GCs did not produce offspring with elevated oxidative 551 stress levels or shorter telomeres may have been because of the effects of maternally-derived 552
GCs on offspring telomerase levels, an enzyme that is capable of rebuilding telomeres or 553 buffering them from attrition (Blackburn, 2005) . We did not measure telomerase levels, but a 554 previous study showed that long-term exposure of laboratory rats to unpredictable stressors 555 increased the production of telomerase (Beery et al., 2012) . Thus, a testable prediction for future 556 studies is that treating mothers with GCs promotes increases in telomerase or enzymatic 557 antioxidant production that has protective effects on offspring. This would be consistent with 558 predictions from the oxidative shielding hypothesis (Blount et al., 2016) that proposes that 559 females may reduce their own levels of oxidative damage (perhaps by upregulation of enzymatic 560 antioxidants) to mitigate their detrimental influence on offspring. 561
Our results indicate that elevated GCs can impact maternal investment in the current 562 litter. Females experiencing elevated GCs during pregnancy increased their investment in the 563 current litter (as indicated by an increase in postnatal growth) whereas females experiencing 564 elevated GCs during lactation tended to reduce their investment in the current litter, the latter 565 possibly being because mothers spent less time interacting or nursing their offspring, as in a 566 previous study in laboratory rats (Nephew and Bridges, 2011) . Alternatively, the reduction in 567 offspring growth when mothers were treated with GCs during lactation could have been because 568 milk quality or content was altered. Life history theory predicts that such changes in maternal 569 investment in offspring could alter the survival or future reproduction of mothers (Stearns, 1992 ) 570 or increase their oxidative stress levels (Monaghan and Haussmann, 2006; Blount et al., 2016) . 571
However, our previous work in red squirrels shows that their food caching nature results in 572 unexpected patterns with respect to the potential costs of reproductive investment. Red squirrels 573 can elevate reproductive output (i.e., producing a second litter or larger litters) in anticipation of 574 increased future food abundance (Boutin et al., 2006) , or produce faster growing offspring when 575 the fitness payoffs warrant increased investment in the current litter (Dantzer et al., 2013) . They 576 seem to be able to do this without additional access to food except the food that they already Although it is not known whether increased antioxidants, reduced oxidative damage, or 594 elongated telomeres actually cause an increase in longevity (Simons, 2015; but see Munoz-595
Lorente et al. 2019), our results suggest that fast growing offspring or those from mothers treated 596 with GCs during pregnancy or lactation would not experience a reduction in lifespan. Our results 597 and our previous study in red squirrels (Dantzer et al., 2013) show that maternal GCs during 598 pregnancy or lactation can induce plasticity in offspring growth and that this plasticity should be 599 adaptive for the fluctuating environments experienced by Yukon red squirrels (Dantzer et al., 600 2013). Specifically, when population density is elevated, females have elevated GCs and fast 601 offspring growth increases offspring survival (Dantzer et al., 2013) . We have shown here that 602 females with elevated GCs during pregnancy produce faster growing offspring, whereas females 603 with elevated GCs during lactation produce slower growing offspring. This suggests that 604 plasticity in GC levels during female reproduction (e.g., females have elevated GCs during 605 pregnancy but exert strong negative feedback on further GC production during lactation) would 606 maximize female reproductive success when density is high. However, we did not find support 607 for the hypothesis that elevated maternal GCs induce a faster pace of life where offspring grow 608 faster and are more competitive early in life but this comes at some oxidative cost that may 609 predict a shortened lifespan. Future studies should assess oxidative stress using an even broader 610 array of measures than the few measures we used here, and will of course need to assess if 611 (GCs) on oxidative stress levels in blood, liver, and heart tissue from weaned juvenile red 904 squirrels. There were no significant treatment effects on oxidative stress levels in the blood (A, 905 B), heart (C, D), or liver (E, F) for offspring produced by mothers treated with GCs during 906 pregnancy (n = 20 pups) or lactation (n = 13) compared with the controls (pregnancy: n = 21; 907 lactation: n = 14, statistical results in Tables S3 & S5 ). Values on y-axes reflect a composite 908 variable generated by separate principal component analyses for blood, heart, and liver tissue 909
where high scores correspond to low levels of one or two of the antioxidants (TAC, SOD) and, 910 for heart, higher levels of protein damage (PCC; see Table 1 ). Note differences between y-axes 911 among the panels. 
(GCs) on mean liver telomere lengths in weaned offspring. A & B)
There were no significant 915 treatment effects on liver telomere lengths for offspring produced by mothers treated with GCs 916 during pregnancy (n = 20 pups) or lactation (n = 13) compared with the controls (pregnancy: n = 917 21; lactation: n = 14, statistical results in Table S4 ). Table S3 . Effects of treating pregnant red squirrels with GCs on oxidative stress levels in 29 (A) blood, (B) heart, and (C) liver tissue from weaned offspring. High PC scores correspond 30 to low levels of antioxidants and, for heart, higher levels of protein damage (see Table 1 ). 31
Models for blood and liver tissues contained random intercept term for litter ID (blood: s 2 = 32 0.32; liver: s 2 = 0.04 
